{"id":"W4406681280","doi":"10.1016/j.kint.2024.07.010","title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary","year":2025,"lang":"en","type":"article","venue":"Kidney International","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Sanofi; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Ono Pharmaceutical; Gilead Sciences; Nierstichting; Servier; Otsuka Pharmaceutical; Medical Research Council; Alexion Pharmaceuticals; Vertex Pharmaceuticals; Ipsen; Maze Therapeutics; Acceleron; World Health Organization; International Society of Nephrology; Cleveland Clinic; Bayer HealthCare; GlaxoSmithKline; National Health and Medical Research Council; AstraZeneca; Danone; Janssen Pharmaceuticals; American Society of Hematology","keywords":"Guideline; Autosomal dominant polycystic kidney disease; Medicine; Executive summary; Kidney disease; Disease; Intensive care medicine; Polycystic kidney disease; Internal medicine; Clinical Practice; Pathology; Family medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004313972,0.0001681938,0.000156846,0.00006500765,0.0001035206,0.00003096646,0.0002387685,0.00006864861,0.00004901762],"category_scores_gemma":[0.003571248,0.0001250048,0.0001714681,0.00006496963,0.0001568957,0.000008980548,0.000132581,0.00003260678,0.000002312358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003993634,"about_ca_system_score_gemma":0.0008397794,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002162048,"about_ca_topic_score_gemma":0.000002247599,"domain_scores_codex":[0.9985404,0.0001084851,0.0005343878,0.000398342,0.0002601044,0.0001582528],"domain_scores_gemma":[0.9985265,0.0001709613,0.0001890344,0.0003351066,0.0004913384,0.000287065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003115733,0.0008164072,0.005818449,0.00004888039,0.001893672,0.000005994149,0.00003217796,0.00004674257,0.00226221,0.001892074,0.9696392,0.01442846],"study_design_scores_gemma":[0.003978324,0.0002255063,0.01340249,0.00006633538,0.001106512,0.000003161055,0.000150948,0.004142837,0.002049533,0.0007335566,0.9740078,0.0001329762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.05119242,0.04897322,0.3060974,0.3630547,0.02104859,0.01858852,0.01917863,0.000127795,0.1717388],"genre_scores_gemma":[0.8401563,0.01019891,0.03666483,0.03866641,0.002107185,0.001837583,0.009292044,0.00007173864,0.06100497],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7889639,"threshold_uncertainty_score":0.5097546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02214863458574915,"score_gpt":0.3719724406006262,"score_spread":0.349823806014877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}